Vedolizumab–steroid combination therapy improves long-term prognosis in patients with ulcerative colitis

Vedolizumab–steroid combination therapy improves long-term prognosis in patients with ulcerative colitis

Abstract Background In real-world clinical settings, the clinical efficacy of vedolizumab (VDZ) in patients with ulcerative colitis (UC) remains unclear. In this study, we aimed to evaluate the efficacy of prednisolone (PSL)–VDZ combination therapy in patients with UC. Methods Changes in the clinica...

Full description

Saved in:
Bibliographic Details
Main Authors: Yosuke Yamada, Natsuki Ishida, Tomohiro Takebe, Kenichi Takahashi, Yusuke Asai, Satoshi Tamura, Tomoharu Matsuura, Ryosuke Takano, Ai Matsuura, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Takanori Yamada, Satoshi Osawa, Yashiro Yoshizawa, Yoshisuke Hosoda, Yuji Ota, Hiroyuki Hanai, Ken Sugimoto
Format: Article
Language:English
Published: BMC 2025-04-01
Series:BMC Gastroenterology
Subjects:
Ulcerative colitis
Vedolizumab
Steroid
C-reactive protein
Online Access:https://doi.org/10.1186/s12876-025-03913-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12876-025-03913-z

Similar Items